MaxQ-AI (previously known as MedyMatch) recently filed for an $8 million IPO. According to Nasdaq, MaxQ-AI filed confidentially on February 13. The prosepectus filed with the SEC describes MaxQ-AI as ...

TEL AVIV, Israel, March 18, 2018 /PRNewswire/ -- MedyMatch Technology, a company focused on assisting physicians provide accurate patient assessment through artificial intelligence-based insights, ...

The Accipio Clinical Platform generates multiple insights into a patient's medical imaging study that may provide a faster and clinically accurate diagnosis. The platform is comprised of Accipio Ix ...

Clinical diagnostic and workflow software maker MaxQ AI has received FDA 510(k) marketing clearance for Accipio Ix, an artificial intelligence workflow tool designed to help clinicians prioritize ...

Fierce 15 winner MaxQ AI, formerly known as MedyMatch, has received a 510(k) clearance from the FDA for its artificial intelligence software that rapidly detects brain bleeds in CT scans. Its Accipio ...

MaxQ AI, a clinical-stage medical device company developing an AI-based medical imaging platform, filed on Thursday with the SEC to raise up to $8 million in an initial public offering. The Tel Aviv, ...

MaxQ AI, which is commercializing an AI-based medical imaging platform, withdrew its plans for a US initial public offering on Friday. The pre-revenue company had filed in August 2018 to raise $8 ...

ANDOVER, Mass. & TEL AVIV, Israel--(BUSINESS WIRE)--MaxQ, a healthcare technology company that provides medical diagnostic AI applications and clinical workflow automation, announced the appointment ...